Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Italian Study Group on Complicated Diverticulosis

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Länken sparas på Urklipp
StatusAvslutad
Sponsorer
Gruppo Italiano per lo Studio della Diverticolite Complicata

Nyckelord

Abstrakt

Patients were recruited over a four year period from 1996 to 1999. Those admitted in the years 1996 and 1997 were retrospectively accrued from the clinical records, while patients treated between 1998 and 1999 patients were entered on the database prospectively on admission.
Inclusion criteria All consecutive patients with left sided acute diverticulitis diagnosed clinically by the presence of abdominal pain, associated with leukocytosis (>11x109) and/or fever >38°C, confirmed by imaging (CT scan, ultrasonography, water soluble contrast enema) either alone or in combination and/or by operative findings, entered the study. The CT criteria for the diagnosis included a localized thickening (≥4 mm) of the colonic wall and signs of inflammation of the pericolic fat, with abscess and/or extraluminal air and/or extraluminal contrast. The criteria for ultrasound included at least two of the following signs: bowel wall thickening (>4 mm), diverticular inflammation, pericolic fat edema, intramural or pericolic inflammatory mass, intramural fistula. The diagnostic criteria for water soluble contrast enema included segmental luminal narrowing and a tethered mucosa with or without a mass effect or extravasation of contrast and/or the presence of extraluminal air.
Exclusion criteria Patients with inflammatory bowel disease, irritable bowel syndrome, colorectal cancer or diseases precluding adequate follow up, were excluded from the study.
Treatment Patients were treated conservatively (antibiotics, I.V. nutrition, CT/US guided abscess drainage) or surgically according to the local policy of each center.
Follow up Follow up was carried out according to local policy. The following data were collected: persistence or recurrence of chronic symptoms attributable to complicated diverticular disease, new episodes of AD, new hospital admissions for AD, type of treatment and outcome.
Recurrence was defined as a new episode of AD requiring hospitalization that occurred at least 2 months after complete resolution of the index episode which resulted in inclusion in the study. If surgery was performed, the timing, type of procedure, Hinchey stage and complications were recorded.
Data collection A standardized flow sheet was used to collect data on medical history, diagnostic work up, type of treatment and follow up to create a dedicated database. Gender, age, date of hospital admission and discharge, diagnosis on admission and discharge, co-morbidities (diabetes mellitus, cardiovascular disease, atherosclerosis, liver or renal failure), symptoms experienced before admission and their duration, history of diverticulosis, previous episodes of AD, laboratory tests, and treatment performed were recorded. Where surgery was performed, the date and type of procedure, the operative findings including Hinchey's classification (16) and details of the operation (incision, extension of resection, type of anastomosis, covering stoma, drains), pathology report, and postoperative complications occurring within 30 days, were all recorded.
End points The primary endpoint was to assess the rate of recurrence of AD requiring hospitalization during the follow-up period. Additional endpoints were to assess the risks of emergency surgery, stoma and disease-related mortality during the follow up.

Datum

Senast verifierad: 11/30/2010
Först skickat: 01/11/2011
Beräknad anmälan inlämnad: 01/11/2011
Först publicerad: 01/12/2011
Senaste uppdatering skickad: 01/20/2011
Senaste uppdatering publicerad: 01/23/2011
Faktiskt startdatum för studien: 12/31/1995
Uppskattat primärt slutdatum: 11/30/1999
Beräknat slutfört datum: 11/30/1999

Tillstånd eller sjukdom

Diverticulitis

Intervention / behandling

Drug: Acute Diverticulitis

Procedure: Acute Diverticulitis

Fas

-

Armgrupper

ÄrmIntervention / behandling
Acute Diverticulitis
Drug: Acute Diverticulitis

Urvalskriterier

Kön som är berättigade till studierAll
TestmetodNon-Probability Sample
Accepterar friska volontärerJa
Kriterier

Inclusion Criteria:

All consecutive patients with left sided acute diverticulitis diagnosed clinically by the presence of:

- abdominal pain,

- leukocytosis (>11x109)

- fever >38°C and confirmed by imaging (CT scan, ultrasonography, water soluble contrast enema)

The CT criteria for the diagnosis included at least one of:

- a localized thickening (≥4 mm) of the colonic wall

- signs of inflammation of the pericolic fat

- abscess

- extraluminal air

- extraluminal contrast

The ultrasound criteria included at least two of:

- bowel wall thickening (>4 mm)

- diverticular inflammation

- pericolic fat edema

- intramural or pericolic inflammatory mass

- intramural fistula

Water soluble contrast enema criteria included at least two of:

- segmental luminal narrowing

- a tethered mucosa

- a mass effect

- extravasation of contrast

- the presence of extraluminal air

Exclusion Criteria:

- inflammatory bowel disease

- irritable bowel syndrome

- colorectal cancer

- diseases precluding adequate follow up

Resultat

Primära resultatåtgärder

1. to assess the rate of recurrence of acute diverticulitis requiring hospitalization during the follow-up period [10 years]

Sekundära resultatåtgärder

1. to assess the risks of emergency surgery, stoma and disease-related mortality during the follow up [10 years]

Gå med på vår
facebook-sida

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen

  • Fungerar på 55 språk
  • Växtbaserade botemedel som stöds av vetenskap
  • Örter igenkänning av bild
  • Interaktiv GPS-karta - märka örter på plats (kommer snart)
  • Läs vetenskapliga publikationer relaterade till din sökning
  • Sök efter medicinska örter efter deras effekter
  • Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent

Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning

Google Play badgeApp Store badge